Ali E. Raslan

Dr. Ali E. Raslan

Al-Azhar University, Assiut, Egypt
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 November 2022 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
LALamya H. Al-Wahaibi
Lamya H. Al-Wahaibi
MMMohamed A. Mahmoud
Mohamed A. Mahmoud
YMYaser A. Mostafa
Yaser A. Mostafa
Ali E. RaslanAli E. Raslan
Ali E. Raslan
BYBahaa G. M. Youssif
Bahaa G. M. Youssif
A new series of piperine-carboximidamide hybrids VIa-k was developed as a new cytotoxic agent targeting EGFR, BRAF, and CDK2. The antiproliferative effect against four cancer cells was investigated against erlotinib. Hybrids VIc, VIf, VIg, VIi, and VIk have the highest antiproliferative activity. Compounds VIc, VIf, VIg, VIi, and VIk inhibited EGFR with IC50 values ranging from 96 to 127 nM. Compounds VIf and VIk had the most potent inhibitory activity as BRAFV600E (IC50 = 49 and 40 nM, respectively) and were discovered to be potent inhibitors of cancer cell proliferation (GI50 = 44 and 35 nM against four cancer cell lines, respectively). Compound VIk, the most effective derivative as an antiproliferative agent, demonstrated potent anti-CDK2 action with an IC50 value of 12 nM, which is 1.5-fold more potent than the reference dinaciclib. Finally, VIc, VIf, and VIk have a high capacity to inhibit LOX-IMVI cell line survival. Graphical Abstract

28 February 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
NENesreen M.I.M. Elkomy
Nesreen M.I.M. Elkomy
AEAmina El-Shaibany
Amina El-Shaibany
GEGehad Elnagar
Gehad Elnagar
AKAhmed Abdel khalek
Ahmed Abdel khalek
HAHassan Al-Mahbashi
Hassan Al-Mahbashi
Ali E. RaslanAli E. Raslan
Ali E. Raslan

1 September 2014 in Phytochemistry Letters
Verified
Journal Article
Closed access
Gamal Abd AllahGamal Abd Allah
Gamal Abd Allah
Ali E. RaslanAli E. Raslan
Ali E. Raslan
HHHashim A. Hassanean
Hashim A. Hassanean
Diaa YoussefDiaa Youssef
Diaa Youssef
RSRob van Soest
Rob van Soest

1 February 2018 in Phytochemistry Letters
Verified
Journal Article
Closed access
Ali E. RaslanAli E. Raslan
Ali E. Raslan
MRMohamed M. Radwan
Mohamed M. Radwan
SASafwat A. Ahmed
Safwat A. Ahmed
ANAlaa M. Nafady
Alaa M. Nafady
MZMohamed Ahmed Zaki
Mohamed Ahmed Zaki
MEMahmoud A. ElSohly
Mahmoud A. ElSohly

24 August 2022 in Phytochemistry Letters
Verified
Journal Article
Closed access
Ali E. RaslanAli E. Raslan
Ali E. Raslan
MRMohamed M. Radwan
Mohamed M. Radwan
SASafwat A. Ahmed
Safwat A. Ahmed
ANAlaa M. Nafady
Alaa M. Nafady
AMAhmed M. Metwaly
Ahmed M. Metwaly
AWAmira S. Wanas
Amira S. Wanas

14 April 2014 in Natural Product Research
Verified
Journal Article
Closed access
Gamal Abd AllahGamal Abd Allah
Gamal Abd Allah
Ali E. RaslanAli E. Raslan
Ali E. Raslan
HHHashim A. Hassanean
Hashim A. Hassanean
AAAbdulrahman M. Alahdal
Abdulrahman M. Alahdal
AAAmeen Almohammadi
Ameen Almohammadi
Diaa YoussefDiaa Youssef
Diaa Youssef
Chemical investigation of the Red Sea sponge Mycale euplectellioides afforded two new compounds; hexacosa-(6Z,10Z)-dienoic acid methyl ester (1) and hexacosa-(6Z,10Z)-dienoic acid (2), along with two known compounds: icosa-(8Z,11Z)-dienoic acid methyl ester (3) and β-sitosterol (4). The structures were elucidated by the interpretation of their spectral data. The total methanol extract (TME) of the sponge exhibited potent antimicrobial activity against the different strains at a concentration of 100 mg/mL. All tested fractions did not exhibit any activity against Serratia marcescens and tested fungal strains. The TME and different fractions displayed anti-inflammatory and antipyretic activities at doses of 100 and 200 mg/kg compared with indomethacin (8 mg). The TME exhibited a remarkable hepato-protective effect in CCl4-induced liver damage compared with silymarin. Furthermore, compounds 1 and 2 displayed weak activity against A549 non-small cell lung cancer, the U373 glioblastoma and the PC-3 prostate cancer cell lines.